Logo image of COHR

COHERENT CORP (COHR) Stock Fundamental Analysis

NYSE:COHR - US19247G1076 - Common Stock

91.58 USD
+1.08 (+1.19%)
Last: 8/26/2025, 8:22:41 PM
92 USD
+0.42 (+0.46%)
Pre-Market: 8/27/2025, 8:10:06 AM
Fundamental Rating

4

COHR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. COHR has an average financial health and profitability rating. COHR is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

COHR had positive earnings in the past year.
COHR had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: COHR reported negative net income in multiple years.
COHR had a positive operating cash flow in 4 of the past 5 years.
COHR Yearly Net Income VS EBIT VS OCF VS FCFCOHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M

1.2 Ratios

The Return On Assets of COHR (-0.22%) is comparable to the rest of the industry.
COHR's Return On Equity of -0.41% is in line compared to the rest of the industry. COHR outperforms 50.81% of its industry peers.
COHR has a Return On Invested Capital of 3.37%. This is comparable to the rest of the industry: COHR outperforms 56.45% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for COHR is significantly below the industry average of 9.70%.
The last Return On Invested Capital (3.37%) for COHR is above the 3 year average (1.88%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.22%
ROE -0.41%
ROIC 3.37%
ROA(3y)-1.8%
ROA(5y)0.14%
ROE(3y)-3.42%
ROE(5y)-0.03%
ROIC(3y)1.88%
ROIC(5y)3.36%
COHR Yearly ROA, ROE, ROICCOHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

With a decent Operating Margin value of 9.86%, COHR is doing good in the industry, outperforming 77.42% of the companies in the same industry.
COHR's Operating Margin has improved in the last couple of years.
The Gross Margin of COHR (34.48%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of COHR has remained more or less at the same level.
Industry RankSector Rank
OM 9.86%
PM (TTM) N/A
GM 34.48%
OM growth 3Y-10.64%
OM growth 5Y23.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.68%
GM growth 5Y0.42%
COHR Yearly Profit, Operating, Gross MarginsCOHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COHR is destroying value.
COHR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, COHR has more shares outstanding
COHR has a better debt/assets ratio than last year.
COHR Yearly Shares OutstandingCOHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
COHR Yearly Total Debt VS Total AssetsCOHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

An Altman-Z score of 2.05 indicates that COHR is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.05, COHR is not doing good in the industry: 68.55% of the companies in the same industry are doing better.
COHR has a debt to FCF ratio of 14.56. This is a negative value and a sign of low solvency as COHR would need 14.56 years to pay back of all of its debts.
With a Debt to FCF ratio value of 14.56, COHR perfoms like the industry average, outperforming 54.03% of the companies in the same industry.
COHR has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
COHR has a worse Debt to Equity ratio (0.48) than 68.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 14.56
Altman-Z 2.05
ROIC/WACC0.35
WACC9.64%
COHR Yearly LT Debt VS Equity VS FCFCOHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

COHR has a Current Ratio of 2.47. This indicates that COHR is financially healthy and has no problem in meeting its short term obligations.
COHR has a Current ratio (2.47) which is comparable to the rest of the industry.
A Quick Ratio of 1.54 indicates that COHR should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.54, COHR is in line with its industry, outperforming 45.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 1.54
COHR Yearly Current Assets VS Current LiabilitesCOHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

7

3. Growth

3.1 Past

COHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.87%, which is quite impressive.
The Earnings Per Share has been growing slightly by 6.89% on average over the past years.
The Revenue has grown by 23.42% in the past year. This is a very strong growth!
Measured over the past years, COHR shows a quite strong growth in Revenue. The Revenue has been growing by 19.54% on average per year.
EPS 1Y (TTM)116.87%
EPS 3Y-1.09%
EPS 5Y6.89%
EPS Q2Q%63.93%
Revenue 1Y (TTM)23.42%
Revenue growth 3Y20.55%
Revenue growth 5Y19.54%
Sales Q2Q%16.39%

3.2 Future

COHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.29% yearly.
COHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.90% yearly.
EPS Next Y29.83%
EPS Next 2Y23.21%
EPS Next 3Y27.29%
EPS Next 5YN/A
Revenue Next Year8.81%
Revenue Next 2Y7.94%
Revenue Next 3Y9.9%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COHR Yearly Revenue VS EstimatesCOHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
COHR Yearly EPS VS EstimatesCOHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

COHR is valuated quite expensively with a Price/Earnings ratio of 25.44.
Compared to the rest of the industry, the Price/Earnings ratio of COHR indicates a somewhat cheap valuation: COHR is cheaper than 69.35% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of COHR to the average of the S&P500 Index (27.08), we can say COHR is valued inline with the index average.
A Price/Forward Earnings ratio of 19.59 indicates a rather expensive valuation of COHR.
COHR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. COHR is cheaper than 70.16% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of COHR to the average of the S&P500 Index (22.67), we can say COHR is valued inline with the index average.
Industry RankSector Rank
PE 25.44
Fwd PE 19.59
COHR Price Earnings VS Forward Price EarningsCOHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

70.16% of the companies in the same industry are more expensive than COHR, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COHR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 55.55
EV/EBITDA 15.33
COHR Per share dataCOHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

COHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as COHR's earnings are expected to grow with 27.29% in the coming years.
PEG (NY)0.85
PEG (5Y)3.69
EPS Next 2Y23.21%
EPS Next 3Y27.29%

0

5. Dividend

5.1 Amount

No dividends for COHR!.
Industry RankSector Rank
Dividend Yield N/A

COHERENT CORP

NYSE:COHR (8/26/2025, 8:22:41 PM)

Premarket: 92 +0.42 (+0.46%)

91.58

+1.08 (+1.19%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners94.79%
Inst Owner Change1.29%
Ins Owners0.6%
Ins Owner Change-1.43%
Market Cap14.24B
Analysts82.14
Price Target112.62 (22.97%)
Short Float %4.59%
Short Ratio1.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.23%
Min EPS beat(2)4.19%
Max EPS beat(2)34.28%
EPS beat(4)4
Avg EPS beat(4)14.27%
Min EPS beat(4)0.45%
Max EPS beat(4)34.28%
EPS beat(8)8
Avg EPS beat(8)19.29%
EPS beat(12)11
Avg EPS beat(12)12.37%
EPS beat(16)15
Avg EPS beat(16)11.12%
Revenue beat(2)2
Avg Revenue beat(2)2.12%
Min Revenue beat(2)1.9%
Max Revenue beat(2)2.33%
Revenue beat(4)4
Avg Revenue beat(4)1.44%
Min Revenue beat(4)0.53%
Max Revenue beat(4)2.33%
Revenue beat(8)6
Avg Revenue beat(8)0.91%
Revenue beat(12)7
Avg Revenue beat(12)-0.4%
Revenue beat(16)9
Avg Revenue beat(16)-0.61%
PT rev (1m)11.15%
PT rev (3m)16.92%
EPS NQ rev (1m)0.43%
EPS NQ rev (3m)0.55%
EPS NY rev (1m)1.71%
EPS NY rev (3m)4.01%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)-1.02%
Revenue NY rev (3m)-0.12%
Valuation
Industry RankSector Rank
PE 25.44
Fwd PE 19.59
P/S 2.54
P/FCF 55.55
P/OCF 21.39
P/B 1.82
P/tB 193.14
EV/EBITDA 15.33
EPS(TTM)3.6
EY3.93%
EPS(NY)4.67
Fwd EY5.1%
FCF(TTM)1.65
FCFY1.8%
OCF(TTM)4.28
OCFY4.68%
SpS35.99
BVpS50.27
TBVpS0.47
PEG (NY)0.85
PEG (5Y)3.69
Profitability
Industry RankSector Rank
ROA -0.22%
ROE -0.41%
ROCE 4.26%
ROIC 3.37%
ROICexc 3.61%
ROICexgc 10.1%
OM 9.86%
PM (TTM) N/A
GM 34.48%
FCFM 4.58%
ROA(3y)-1.8%
ROA(5y)0.14%
ROE(3y)-3.42%
ROE(5y)-0.03%
ROIC(3y)1.88%
ROIC(5y)3.36%
ROICexc(3y)2.02%
ROICexc(5y)4.59%
ROICexgc(3y)5.76%
ROICexgc(5y)9.96%
ROCE(3y)2.38%
ROCE(5y)4.25%
ROICexcg growth 3Y-16.97%
ROICexcg growth 5Y25.42%
ROICexc growth 3Y-25.76%
ROICexc growth 5Y17.93%
OM growth 3Y-10.64%
OM growth 5Y23.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.68%
GM growth 5Y0.42%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 14.56
Debt/EBITDA 3.35
Cap/Depr 72.79%
Cap/Sales 7.32%
Interest Coverage 2
Cash Conversion 59.74%
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 1.54
Altman-Z 2.05
F-Score6
WACC9.64%
ROIC/WACC0.35
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.87%
EPS 3Y-1.09%
EPS 5Y6.89%
EPS Q2Q%63.93%
EPS Next Y29.83%
EPS Next 2Y23.21%
EPS Next 3Y27.29%
EPS Next 5YN/A
Revenue 1Y (TTM)23.42%
Revenue growth 3Y20.55%
Revenue growth 5Y19.54%
Sales Q2Q%16.39%
Revenue Next Year8.81%
Revenue Next 2Y7.94%
Revenue Next 3Y9.9%
Revenue Next 5YN/A
EBIT growth 1Y226.98%
EBIT growth 3Y7.72%
EBIT growth 5Y47.17%
EBIT Next Year47.54%
EBIT Next 3Y24.67%
EBIT Next 5YN/A
FCF growth 1Y13.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y17.83%
OCF growth 3YN/A
OCF growth 5YN/A